Renee N Donahue Selected Research

Neoplasm Antigens (Tumor Antigens)

1/2020	Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer.
6/2016	The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
11/2014	Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renee N Donahue Research Topics

Disease

53	Neoplasms (Cancer) 03/2024 - 08/2008
11	Prostatic Neoplasms (Prostate Cancer) 05/2023 - 10/2014
10	Carcinoma (Carcinomatosis) 01/2023 - 10/2009
6	Vaccinia 05/2023 - 05/2014
6	Ovarian Neoplasms (Ovarian Cancer) 02/2012 - 06/2009
5	Necrosis 01/2023 - 10/2010
5	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2016
4	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 08/2008
4	Chordoma 01/2021 - 11/2015
4	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2014
3	Triple Negative Breast Neoplasms 05/2024 - 12/2023
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2023
3	Human Influenza (Influenza) 01/2021 - 05/2016
3	COVID-19 01/2021 - 10/2020
2	Disease Progression 05/2023 - 10/2019
2	Fowlpox 05/2023 - 05/2014
2	Injection Site Reaction 01/2023 - 11/2015
2	Fatigue 01/2021 - 01/2017
2	Infections 01/2021 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 08/2008
2	Thymoma (Thymic Carcinoma) 10/2019 - 01/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 01/2017
2	Communicable Diseases (Infectious Diseases) 05/2016 - 01/2016
2	Carcinogenesis 11/2014 - 07/2011
2	Autoimmune Diseases (Autoimmune Disease) 05/2011 - 01/2011
1	Circulating Neoplastic Cells 03/2024
1	Capillary Leak Syndrome 01/2023
1	Overweight 01/2022
1	Papilloma (Papillomatosis) 01/2021
1	Mastodynia 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Lymphopenia (Lymphocytopenia) 11/2020

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 05/2023 - 05/2014
12	AntigensIBA 11/2023 - 01/2012
10	avelumabIBA 01/2023 - 05/2016
10	Opioid Analgesics (Opioids)IBA 02/2012 - 06/2009
9	methionine-enkephalin receptorIBA 02/2012 - 08/2008
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 06/2009
8	Brachyury protein (Brachyury)IBA 01/2021 - 11/2015
7	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2019
7	PROSTVACIBA 05/2023 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2012
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2010
6	Cancer VaccinesIBA 01/2020 - 01/2012
5	Monoclonal AntibodiesIBA 01/2023 - 05/2016
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2015
5	Immunoglobulin G (IgG)IBA 12/2020 - 01/2017
4	NivolumabIBA 05/2024 - 01/2023
4	LigandsIBA 03/2024 - 01/2018
4	CytokinesIBA 09/2023 - 01/2019
4	Prostate-Specific Antigen (Semenogelase)IBA 05/2023 - 08/2014
4	B7-H1 AntigenIBA 10/2019 - 01/2018
4	EnkephalinsIBA 05/2011 - 06/2009
3	Capecitabine (Xeloda)FDA Link 05/2024 - 12/2023
3	Interleukin-12 (IL 12)IBA 01/2023 - 01/2019
3	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021 - 08/2019
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 11/2014
3	Docetaxel (Taxotere)FDA Link 10/2016 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2024
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2024 - 12/2020
2	Histones (Histone)IBA 01/2023 - 01/2019
2	Bevacizumab (Avastin)FDA Link 11/2022 - 01/2015
2	Testosterone (Sustanon)FDA Link 01/2022 - 01/2021
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 01/2018
2	enzalutamideIBA 01/2021 - 10/2014
2	AndrogensIBA 01/2021 - 10/2014
2	Histone Deacetylase InhibitorsIBA 01/2020 - 01/2018
2	entinostat (MS 275)IBA 01/2020 - 01/2018
2	B7 AntigensIBA 08/2019 - 11/2017
2	Peptides (Polypeptides)IBA 05/2016 - 10/2009
2	Sunitinib (Sutent)FDA Link 01/2015 - 11/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 11/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 11/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 11/2014
2	cabozantinibIBA 01/2015 - 11/2014
2	Opioid Receptors (Opioid Receptor)IBA 09/2011 - 07/2011
2	Naltrexone (ReVia)FDA LinkGeneric 08/2011 - 07/2011
2	Opioid Peptides (Opioid Peptide)IBA 07/2011 - 01/2011
1	Circulating Tumor DNAIBA 03/2024
1	Flutamide (Eulexin)FDA LinkGeneric 01/2023
1	Recombinant Fusion ProteinsIBA 01/2023
1	Immunotoxins (Immunotoxin)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	bicalutamide (Casodex)FDA LinkGeneric 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	SteroidsIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020
1	Methylprednisolone FDA LinkGeneric 11/2020
1	GlucocorticoidsIBA 11/2020

Therapy/Procedure

24	Therapeutics 03/2024 - 07/2011
18	Immunotherapy 03/2024 - 01/2012
8	Drug Therapy (Chemotherapy) 03/2024 - 10/2014
6	Castration 01/2023 - 10/2014
2	Aftercare (After-Treatment) 01/2021 - 01/2012
2	Radiotherapy 01/2021 - 01/2012
1	Intravenous Administration 01/2021